Clinical trial
Treatment of Recurrent Hepatitis C After Liver Transplantation
NCT00151580 · Rennes University Hospital, Other · Completed
Key facts
| NCT number | NCT00151580 |
|---|---|
| Title | Treatment of Recurrent Hepatitis C After Liver Transplantation |
| Official title | Comparison of Maintenance Treatment by Ribavirin to a Placebo, After an Initial One-year Treatment With Pegylated Interferon-α2a - Ribavirin Association in Hepatitis C Viral Recurrence After Liver Transplantation |
| Acronym | TRANSPEG |
| Lead sponsor | Rennes University Hospital, Other |
| Collaborators | Ministry of Health, France ANRS, Emerging Infectious Diseases |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Liver Transplantation, Hepatitis C |
| Intervention type | Drug |
| Interventions | Ribavirin, Placebo |
| Enrollment | 200 |
| Start date | Feb 1, 2002 |
| Completion | Jul 1, 2006 |
| First posted | Sep 9, 2005 |
| Last update posted | May 21, 2012 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: